DeepMed Research

University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Cranial Blocks for Postoperative Anesthesia

Phase 4

Terminated

Conditions: Craniotomy Surgery

Interventions: Drug: Bupivacaine Injection
Drug: Liposomal bupivacaine
Drug: Saline

First Posted Date: 2021-02-11

Last Posted Date: 2023-09-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11

Registration Number: NCT04749797

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Incentives & Motivation for Behavior Change:

Not Applicable

Completed

Conditions: Behavior
Intention

Interventions: Behavioral: incentive lottery medium
Behavioral: cash large
Behavioral: mandate public
Behavioral: employer mandate
Behavioral: invitation for sleep financial incentive
Behavioral: invitation for sleep social incentive study
Behavioral: incentive reward
Behavioral: penalty
Behavioral: cash small
Behavioral: cash medium
Behavioral: incentive lottery small
Behavioral: incentive lottery large
Behavioral: invitation for exercise financial incentive study
Behavioral: invitation for exercise social incentive study

First Posted Date: 2021-02-10

Last Posted Date: 2024-02-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4000

Registration Number: NCT04747327

Locations: 🇺🇸
Center for Mental Health. Perelman School of Medicine, Philadelphia, Pennsylvania, United States

Online Wellness Intervention for College Students

Not Applicable

Conditions: Depression
Anxiety
Well-being

Interventions: Behavioral: The Common Elements Toolbox (COMET)

First Posted Date: 2021-02-05

Last Posted Date: 2021-05-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 850

Registration Number: NCT04740411

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Phase 2

Recruiting

Conditions: Cystic Fibrosis
Diabetes
Pancreatic Insufficiency
Abnormal Glucose Tolerance

Interventions: Drug: Dulaglutide 0.75Mg/0.5Ml Inj Pen

First Posted Date: 2021-01-29

Last Posted Date: 2025-04-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT04731272

Locations: 🇺🇸
Children's Hospital of Colorado, Aurora, Colorado, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

A Trial of Project ImPACT in Early Intervention

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Project ImPACT

First Posted Date: 2021-01-28

Last Posted Date: 2025-04-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 79

Registration Number: NCT04729127

Locations: 🇺🇸
Center for Mental Health, Philadelphia, Pennsylvania, United States

TumorGlow Intraoperative Molecular Imaging (IMI)

Phase 1

Recruiting

Conditions: Tumor, Solid

Interventions: Drug: Indocyanine Green

First Posted Date: 2021-01-26

Last Posted Date: 2024-10-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 500

Registration Number: NCT04723810

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Regeneron 1331 Kinetics Sub-Study HoFH

Not Applicable

Completed

Conditions: Hypercholesterolemia, Familial

Interventions: Other: Kinetics test

First Posted Date: 2021-01-25

Last Posted Date: 2021-05-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4

Registration Number: NCT04722068

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇳🇱
Department of Vascular Medicine Amsterdam UMC, Amsterdam, AZ, Netherlands

Effects of Insomnia Treatment on Metabolism in Patients With Depression

Not Applicable

Completed

Conditions: Depression
Insomnia
Insomnia Chronic
Insomnia, Primary
Depressive Symptoms

Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I)

First Posted Date: 2021-01-22

Last Posted Date: 2023-01-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT04719143

Locations: 🇺🇸
The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Ferumoxytol Enhanced Hyperfine Low Field Strength MRI

Completed

Conditions: Anemia, Hemolytic

Interventions: Device: Hyperfine Portable MRI

First Posted Date: 2021-01-22

Last Posted Date: 2022-12-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2

Registration Number: NCT04721262

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

UPenn Observational Research Repository on Neurodegenerative Disease

Recruiting

Conditions: Amyotrophic Lateral Sclerosis(ALS)
Lewy Body Disease(LBD)
Alzheimer's Disease(AD)
Frontotemporal Degeneration(FTD)
Familial Frontotemporal Lobar Degeneration (fFTLD)
Corticobasal Syndrome(CBS)
Posterior Cortical Atrophy(PCA)
Primary Progressive Aphasia(PPA)
Progressive Supranuclear Palsy(PSP)

Interventions: Other: No intervention

First Posted Date: 2021-01-20

Last Posted Date: 2025-01-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1000

Registration Number: NCT04715399

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy